SEC 13F Intelligence

Bennicas & Associates, Inc. / AMGN

Bennicas & Associates, Inc.’s Amgen Inc Position

Does Bennicas & Associates, Inc. own Amgen Inc (AMGN)? Yes — 11.9K shares worth $3M (+1.81% of its 13F portfolio) as of Q1 2023.

Position Value
$3M
Q1 2023
Shares
11.9K
% of Portfolio
+1.81%
Quarters Held
10
currently held

Position History AMGN

Reported value by quarter
Q4 ’20: $3MQ4 ’20Q1 ’21: $3MQ2 ’21: $3MQ2 ’21Q3 ’21: $2MQ4 ’21: $3MQ4 ’21Q1 ’22: $3MQ2 ’22: $3MQ2 ’22Q3 ’22: $3MQ4 ’22: $3MQ4 ’22Q1 ’23: $3Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202311.9K$3M+1.81%
Q4 202211.9K$3M+1.81%
Q3 202212.1K$3M+1.73%
Q2 202212.2K$3M+1.73%
Q1 202212.3K$3M+1.50%
Q4 202112.5K$3M+1.46%
Q3 202110.8K$2M+1.29%
Q2 202110.8K$3M+1.45%
Q1 202110.8K$3M+1.55%
Q4 202011.5K$3M+1.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bennicas & Associates, Inc.’s full portfolio or all institutional holders of AMGN.